Diastolic Heart Failure in Dialysis Patients: Mechanisms, Diagnostic Approach, and Treatment
Authors:
- Roberto Pecoits‐FilhoRPRoberto Pecoits‐Filho
- Sérgio BucharlesSBSérgio Bucharles
- Silvio H. BarberatoSBSilvio H. Barberato
- 24 January 2012
- journal article
- review article
- Published by Wiley in Seminars in Dialysis
- Vol. 25 (1) , 35-41
Abstract
Heart failure (HF) is very common in the general population, and risk factors for HF, such as coronary artery disease, diabetes, obesity, and hypertension, are frequently present in patients with CKD. Therefore, HF is also an important cause of morbidity and mortality in this population. Diastolic heart failure (DHF), also called HF with preserved ejection fraction, refers to a clinical syndrome in which patients have symptoms and signs of HF, normal or near normal left ventricular (LV) systolic function, and evidence of diastolic dysfunction (e.g., abnormal LV filling and elevated filling pressure). Recent data suggest that HF with normal ejection fraction is even more common in patients than HF with low ejection fraction, including those on hemodialysis. Not surprisingly, DHF is a strong predictor of death in CKD patients. In this article, we review the information available on the mechanisms, clinical presentation, impact, and potential interventions in DHF based on evidence from CKD patients, as well as evidence from the general population potentially applicable to the CKD population.Keywords
This publication has 61 references indexed in Scilit:
- Mineralocorticoid receptor blockade improves diastolic function independent of blood pressure reduction in a transgenic model of RAAS overexpressionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2011
- In-Center Hemodialysis Six Times per Week versus Three Times per WeekNew England Journal of Medicine, 2010
- Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patientsEuropean Heart Journal, 2010
- Physiologic Basis and Pathophysiologic Implications of the Diastolic Properties of the Cardiac MuscleJournal of Biomedicine and Biotechnology, 2010
- Cholecalciferol Supplementation in Hemodialysis PatientsClinical Journal of the American Society of Nephrology, 2010
- Left Ventricular Mass in Chronic Kidney Disease and ESRDClinical Journal of the American Society of Nephrology, 2009
- Spironolactone Attenuates Experimental Uremic Cardiomyopathy by Antagonizing MarinobufageninHypertension, 2009
- Erythropoietin Therapy and Left Ventricular Mass Index in CKD and ESRD PatientsClinical Journal of the American Society of Nephrology, 2009
- Uremic cardiac hypertrophy is reversed by rapamycin but not by lowering of blood pressureKidney International, 2009
- Impact of left ventricular hypertrophy on survival in end-stage renal diseaseKidney International, 1989